Meeting Banner
Abstract #4095

Initial Clinical Experience with a Radiation Oncology Dedicated Open 1.0T MR-Simulation

Carri K Glide-Hurst 1 , Ning Wen 1 , David Hearshen 1 , Milan Pantelic 1 , Bo Zhao 1 , Yanle Hu 2 , Tina Kunkel 1 , Kenneth Levin 1 , Benjamin Movsas 1 , Indrin J. Chetty 1 , and M. Salim Siddiqui 1

1 Henry Ford Health System, Detroit, MI, United States, 2 Washington University, St Louis, MO, United States

Due to its excellent soft tissue contrast, MRI is integrated as an adjunct to computed tomography simulation (CT-SIM) for radiotherapy (RT) treatment planning to assist in tumor and organ at risk delineation. Recently, dedicated MR simulation (MR-SIM) platforms for radiation oncology have been introduced, although paucity in the literature exists on how to fully implement MR-SIM into the clinic. This work describes our experience with characterizing system performance, establishes quality assurance (QA) programs, and sets the context for dedicated MR-SIM for RT. We developed QA procedures and workflow necessary to implement MR-SIM into treatment planning and demonstrate its clinical use.

This abstract and the presentation materials are available to members only; a login is required.

Join Here